Juno Therapeutics Inc. (JUNO) Climbed To A 6-Month High On Study Results

Juno Therapeutics Inc. (JUNO) reported positive results from studies of its JCAR014 and JCAR017 chimeric antigen receptor T cell product candidates on Saturday.

from RTT - Before the Bell http://ift.tt/1U5EENh
via IFTTT